<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03346824</url>
  </required_header>
  <id_info>
    <org_study_id>6946</org_study_id>
    <nct_id>NCT03346824</nct_id>
  </id_info>
  <brief_title>Levosimendan Efficacy for Veno-arterial ECMO Weaning: a Retrospective Study</brief_title>
  <acronym>LEVO-ECMO</acronym>
  <official_title>Levosimendan Efficacy for Veno-arterial ECMO Weaning: a Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Failure of Weaning from ECMO is a serious complication, reaching an incidence between 29 and
      58%. Inotrops are frequently used to help separating patient from ECMO. Levosimendan is an
      ino-dilatatory medication and was used in different clinical settings. The aim of this study
      was to evaluate the benefit with levosimendan when used in weaning process.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 15, 2017</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the incidence of weaning failure between patients with levosimendan and others</measure>
    <time_frame>Data were recorded from admission until 48 hours after weaning from ECMO</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">65</enrollment>
  <condition>Cardiogenic Shock</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patient who required the use of short-term assistance
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18

          -  Patient requiring the need for short-term assistance

          -  Patient who has agreed to use his medical data for research purposes

        Exclusion Criteria:

          -  Refusal to participate in the study

          -  Non-weaning attempts due to a death under assistance or a relay by a long-term
             assistance or heart transplant

          -  Non-cardiac indications of assistance (indication of pulmonary replacement)

          -  Subject under guardianship or curatorship
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Gharib AJOB, MD</last_name>
    <phone>33 3 69 55 15 70</phone>
    <email>gharib.ajob@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guillaume HAFFNER, MD</last_name>
    <phone>33 3 69 55 15 70</phone>
    <email>guillaume.haffner@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service RÃ©animation chirurgicale cardiovasculaire-NHC</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gharib AJOB, MD</last_name>
      <phone>33 3 69 55 15 70</phone>
      <email>gharib.ajob@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Guillaume HAFFNER, MD</last_name>
      <phone>33 3 69 55 15 70</phone>
      <email>guillaume.haffner@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Gharib AJOB, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume HAFFNER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>November 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 17, 2017</study_first_posted>
  <last_update_submitted>February 23, 2018</last_update_submitted>
  <last_update_submitted_qc>February 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Levosimendan</keyword>
  <keyword>Veno-arterial ECMO</keyword>
  <keyword>Weaning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shock, Cardiogenic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Simendan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

